Safety and efficacy of Philips' Stellarex .035 low-dose drug-coated balloon demonstrated in clinical trials at three years - Associated Press https://t.co/EWcND8WOF4
— IDRO (@IDROOhio) May 30, 2019
from Twitter https://twitter.com/IDROOhio
May 29, 2019 at 10:02PM
No comments:
Post a Comment